Patents by Inventor Hyun-Myoung Cha

Hyun-Myoung Cha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11673948
    Abstract: Disclosed is anti-TNF/IFN scFv-Fc bispecific antibody and a pharmaceutical composition for prevention or treatment of inflammatory bowel disease, the composition containing the antibody. The bispecific antibody has a structure in which an Fc fragment is conjugated to an scFv bispecific antibody. Thus, a purification process thereof may be easy. The bispecific antibody may effectively and simultaneously conjugate to TNF-? and IFN-? which independently play an important role in inducing Crohn's disease. Thus, the bispecific antibody may exhibit excellent effects in the treatment of inflammatory bowel disease including Crohn's disease.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: June 13, 2023
    Assignee: JP DUETBIO CO., LTD
    Inventors: Dong-Il Kim, Hyun-Myoung Cha, Jin-Hyuk Lim
  • Publication number: 20220177571
    Abstract: Disclosed is anti-TNF/IFN scFv-Fc bispecific antibody and a pharmaceutical composition for prevention or treatment of inflammatory bowel disease, the composition containing the antibody. The bispecific antibody has a structure in which an Fc fragment is conjugated to an scFv bispecific antibody. Thus, a purification process thereof may be easy. The bispecific antibody may effectively and simultaneously conjugate to TNF-? and IFN-? which independently play an important role in inducing Crohn's disease. Thus, the bispecific antibody may exhibit excellent effects in the treatment of inflammatory bowel disease including Crohn's disease.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 9, 2022
    Applicant: JP DUETBIO CO., LTD
    Inventors: Dong-Il KIM, Hyun-Myoung Cha, Jin-Hyuk Lim